Measures IgM antibodies against beta-2 glycoprotein I. When present, they may be part of an antiphospholipid antibody pattern associated with increased clotting risk.
Helps assess possible antiphospholipid syndrome in people with blood clots or pregnancy complications, usually interpreted together with lupus anticoagulant and anticardiolipin tests.